Log in to save to my catalogue

The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic...

The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6e46df4151b04affa21678e1243d004d

The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Bariatric surgery is effective for the treatment and remission of obesity and type 2 diabetes, but pharmacological approaches which exert similar metabolic adaptations are needed to avoid post-surgical complications. Here we show how G49, an oxyntomodulin (OXM) analog and dual glucagon/glucagon-like peptide-1 receptor (GCGR/GLP-1R) agonist, trigger...

Alternative Titles

Full title

The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6e46df4151b04affa21678e1243d004d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6e46df4151b04affa21678e1243d004d

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-024-54080-w

How to access this item